US5853978A
(en)
*
|
1985-12-04 |
1998-12-29 |
Genentech, Inc. |
Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
|
US6534285B1
(en)
|
1984-12-24 |
2003-03-18 |
Genentech, Inc. |
Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
|
US8597910B1
(en)
|
1985-04-11 |
2013-12-03 |
Children's Medical Center Corporation |
DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells
|
US5851991A
(en)
*
|
1987-08-31 |
1998-12-22 |
The Regents Of The University Of California |
Therapeutic use of the retinoblastoma susceptibility gene product
|
US5070013A
(en)
*
|
1988-05-31 |
1991-12-03 |
Schering Corporation |
Immunochemical assay for human granulocyte-macrophage colony stimulating factor
|
US5298599A
(en)
*
|
1988-12-30 |
1994-03-29 |
Oklahoma Medical Research Foundation |
Expression and purification of recombinant soluble tissue factor
|
US5639624A
(en)
*
|
1989-03-14 |
1997-06-17 |
Board Of Regents Of The University Of Nebraska |
Monoclonal antibodies specific for metallic cations and method therefor
|
US6143508A
(en)
*
|
1989-06-29 |
2000-11-07 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Device and process for cell capture and recovery
|
CA1340565C
(en)
|
1989-06-29 |
1999-05-25 |
Thomas B. Okarma |
Device and process for cell capture and recovery
|
US5179007A
(en)
*
|
1989-07-07 |
1993-01-12 |
The Texas A & M University System |
Method and vector for the purification of foreign proteins
|
AU7166891A
(en)
*
|
1990-01-24 |
1991-08-21 |
Upjohn Company, The |
Method of purifying recombinant polypeptides
|
AT396939B
(de)
*
|
1990-05-29 |
1993-12-27 |
Alois Dipl Ing Dr Jungbauer |
Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
|
NZ240558A
(en)
*
|
1990-11-14 |
1994-11-25 |
Smithkline Beecham Corp |
Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
|
US5292646A
(en)
*
|
1991-02-06 |
1994-03-08 |
Genetics Institute, Inc. |
Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
|
DE4105400A1
(de)
*
|
1991-02-21 |
1992-08-27 |
Behringwerke Ag |
Definierte beschichtung mit rekombinanten fusionsproteinen aus konstantem fusionspartner und variablem antigenanteil in diagnostischen testsystemen
|
US5939531A
(en)
*
|
1991-07-15 |
1999-08-17 |
Novartis Corp. |
Recombinant antibodies specific for a growth factor receptor
|
US6028177A
(en)
*
|
1991-10-04 |
2000-02-22 |
Washington University |
Methods of detecting single-chain forms of the glycoprotein hormone quartet
|
US20040063093A1
(en)
*
|
1992-04-08 |
2004-04-01 |
Pfizer, Inc. |
Recombinant feline coronavirus S proteins
|
WO1993023541A1
(en)
*
|
1992-05-18 |
1993-11-25 |
Genentech, Inc. |
Hepatocyte growth factor variants
|
US5316921A
(en)
*
|
1992-05-18 |
1994-05-31 |
Genentech, Inc. |
Single-chain hepatocyte growth factor variants
|
JP3662948B2
(ja)
*
|
1992-12-09 |
2005-06-22 |
ニユー・イングランド・バイオレイブス・インコーポレイテツド |
改質タンパク質及びその製造法
|
DK0730740T3
(da)
*
|
1993-11-23 |
1998-09-28 |
Genentech Inc |
Kinasereceptoraktiveringsassay
|
US6287784B1
(en)
|
1993-11-23 |
2001-09-11 |
Genentech, Inc. |
Kinase receptor activation assay
|
US6492106B1
(en)
*
|
1994-06-27 |
2002-12-10 |
The Johns Hopkins University |
Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
|
WO1996010649A1
(en)
*
|
1994-09-30 |
1996-04-11 |
Southwest Foundation For Biomedical Research |
Isolated human hepatitis b virus polymerase and uses thereof
|
US5731425A
(en)
*
|
1994-10-28 |
1998-03-24 |
Eastman Kodak Company |
Polypeptide surface marker for cells
|
US5770442A
(en)
|
1995-02-21 |
1998-06-23 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral fiber protein and methods of using same
|
US6054289A
(en)
*
|
1995-08-30 |
2000-04-25 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human ADA2
|
US5807708A
(en)
*
|
1996-07-30 |
1998-09-15 |
Millennium Pharmaceuticals, Inc. |
Conservin nucleic acid molecules and compositions
|
US20020102706A1
(en)
*
|
1997-06-18 |
2002-08-01 |
Genentech, Inc. |
Apo-2DcR
|
BR9809173A
(pt)
*
|
1997-05-28 |
2000-08-01 |
Genvec Inc |
Adenovìrus alternativamente direcionados
|
US20030166106A1
(en)
*
|
1997-09-18 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
DE69838483T2
(de)
*
|
1997-10-14 |
2008-07-03 |
Darwin Molecular Corp. |
Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
|
DE69839529D1
(de)
*
|
1997-12-24 |
2008-07-03 |
Ludwig Inst Cancer Res |
Expressionsvektoren und zellinien zur expression von vaskulärem wachstumsfaktor d, sowie verfahren zur behandlung von melanomen
|
CA2263784A1
(en)
|
1998-03-23 |
1999-09-23 |
Megabios Corporation |
Dual-tagged proteins and their uses
|
AU5493899A
(en)
*
|
1998-08-26 |
2000-03-21 |
Salem-Teikyo University |
Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes
|
CA2352532C
(en)
|
1998-11-27 |
2014-10-14 |
Darwin Discovery Ltd. |
Compositions and methods for increasing bone mineralization
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6379903B1
(en)
|
1999-10-08 |
2002-04-30 |
Sigma-Aldrich Co. |
Purification of recombinant proteins fused to multiple epitopes
|
ATE502941T1
(de)
|
2000-04-25 |
2011-04-15 |
Icos Corp |
Hemmer der menschlichen phosphatidyl-inositol-3- kinase delta
|
EP1939203B1
(de)
|
2000-04-25 |
2014-11-19 |
ICOS Corporation |
Hemmer der delta-Isoform der menschlichen Phosphatidyl-Inositol-3-Kinase
|
US6756215B1
(en)
|
2000-10-20 |
2004-06-29 |
The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services |
Functionalized TGF-β fusion proteins
|
US6977293B1
(en)
|
2000-11-03 |
2005-12-20 |
Ceres, Inc. |
Chimeric polypeptides
|
US20020081617A1
(en)
*
|
2000-11-08 |
2002-06-27 |
Tione Buranda |
Fluorescence and FRET based assays for biomolecules on beads
|
WO2004022006A2
(en)
|
2002-09-09 |
2004-03-18 |
Arbor Vita Corporation |
Methods of diagnosing cervical cancer
|
US7276605B2
(en)
*
|
2001-02-01 |
2007-10-02 |
Roche Diagnostics Operations, Inc. |
Method for producing recombinant trypsin
|
DE10112851C1
(de)
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
WO2002090600A2
(en)
|
2001-05-08 |
2002-11-14 |
Darwin Molecular Corporation |
A method for regulating immune function in primates using the foxp3 protein
|
CA2451654A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Ceres, Inc. |
Chimeric histone acetyltransferase polypeptides
|
US6902914B2
(en)
*
|
2001-09-28 |
2005-06-07 |
Sigma-Aldrich, Co. |
Recombinant DNA processes using a dNTP mixture containing modified nucleotides
|
US7799561B2
(en)
*
|
2002-06-12 |
2010-09-21 |
Sigma-Aldrich, Co. |
Affinity peptides and method for purification of recombinant proteins
|
WO2004025259A2
(en)
*
|
2002-09-12 |
2004-03-25 |
Molecular Probes, Inc. |
Site-specific labeling of affinity tags in fusion proteins
|
US20040137643A1
(en)
*
|
2002-12-02 |
2004-07-15 |
John Humphreys |
Immunodetection and quantification methods
|
WO2004071168A2
(en)
*
|
2003-02-05 |
2004-08-26 |
Divergence, Inc. |
Nucleic acids encoding anthelmintic agents and plants made therefrom
|
JP2006525807A
(ja)
*
|
2003-05-02 |
2006-11-16 |
シグマ−アルドリッチ・カンパニー |
固相細胞溶解および捕捉プラットフォーム
|
US7368629B2
(en)
*
|
2004-02-04 |
2008-05-06 |
Divergence, Inc. |
Nucleic acids encoding anthelmintic agents and plants made therefrom
|
US7932260B2
(en)
|
2004-05-13 |
2011-04-26 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
WO2006026248A1
(en)
|
2004-08-25 |
2006-03-09 |
Sigma-Aldrich Co. |
Compositions and methods employing zwitterionic detergent combinations
|
US7741053B2
(en)
*
|
2005-05-13 |
2010-06-22 |
Sigma-Aldrich Co. |
Processes for purification of recombinant proteins
|
JP2008546392A
(ja)
*
|
2005-06-17 |
2008-12-25 |
バイオレクシス ファーマシューティカル コーポレーション |
固定されたトランスフェリン融合タンパク質ライブラリー
|
EP1896504B1
(de)
*
|
2005-06-17 |
2012-11-21 |
Wyeth LLC |
VERFAHREN ZUR REINIGUNG FC-REGIONSHALTIGER ANTIKöRPER
|
EP2006381B1
(de)
|
2006-03-31 |
2016-02-03 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zur kontrolle der blut-pharmakokinetik von antikörpern
|
EP1878744A1
(de)
*
|
2006-07-13 |
2008-01-16 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Epitope-Tag für an der Oberfläche exprimierte T-Zell Rezeptor Proteine, deren Anwendung und Verfahren zur Selection von Wirtszellen, die sie exprimieren
|
EP2083073B1
(de)
|
2006-10-11 |
2013-09-04 |
Oriental Yeast Co., Ltd. |
Fusionsprotein aus löslichem rankl mit epitop-tag enthaltendes reagens
|
MX2009006398A
(es)
|
2006-12-12 |
2009-06-23 |
Biorexis Pharmaceutical Corp |
Genotecas de proteinas de fusion de transferrina.
|
CA2680832A1
(en)
*
|
2007-03-27 |
2008-10-02 |
Merck & Co., Inc. |
Method for detecting autoprocessed, secreted pcsk9
|
DE102007037068A1
(de)
|
2007-08-04 |
2009-02-05 |
Brahms Aktiengesellschaft |
Verfahren zur Detektion von Analyten
|
ES2420969T3
(es)
|
2007-06-22 |
2013-08-28 |
B.R.A.H.M.S Gmbh |
Procedimiento para la detección de analitos
|
DE102007029766A1
(de)
|
2007-06-22 |
2008-12-24 |
Brahms Aktiengesellschaft |
Verfahren zur Detektion von Analyten
|
PL2202245T3
(pl)
|
2007-09-26 |
2017-02-28 |
Chugai Seiyaku Kabushiki Kaisha |
Sposób modyfikowania punktu izoelektrycznego przeciwciała poprzez podstawienie aminokwasu w cdr
|
WO2009064802A2
(en)
*
|
2007-11-13 |
2009-05-22 |
Eli Lilly & Co. |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
ES2563483T3
(es)
|
2008-04-11 |
2016-03-15 |
Chugai Seiyaku Kabushiki Kaisha |
Molécula de unión a antígeno capaz de unirse repetidamente a dos o más moléculas de antígeno
|
WO2010058023A1
(en)
|
2008-11-24 |
2010-05-27 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh |
High affinity t cell receptor and use thereof
|
WO2010089412A1
(en)
|
2009-02-09 |
2010-08-12 |
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) |
Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof
|
EP2258719A1
(de)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Mehrfachziel-T-Zellen-Rezeptor
|
US8440651B2
(en)
|
2010-02-22 |
2013-05-14 |
F. Hoffmann-La Roche Ag |
Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
|
RU2013104038A
(ru)
|
2010-07-14 |
2014-08-20 |
Ф. Хоффманн-Ля Рош Аг |
СЕЛЕКТИВНЫЕ В ОТНОШЕНИИ PI3K p110 ДЕЛЬТА ПУРИНОВЫЕ СОЕДИНЕНИЯ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
US20140234340A1
(en)
|
2010-11-30 |
2014-08-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
|
WO2012154272A1
(en)
|
2011-02-25 |
2012-11-15 |
Wellstat Diagnostics, Llc |
Assays for detecting enzymatic activity
|
SG10201609665PA
(en)
|
2011-02-25 |
2017-01-27 |
Chugai Pharmaceutical Co Ltd |
FcɣRIIb-SPECIFIC Fc ANTIBODY
|
WO2012133782A1
(ja)
*
|
2011-03-30 |
2012-10-04 |
中外製薬株式会社 |
抗原結合分子の血漿中滞留性と免疫原性を改変する方法
|
SI2734538T1
(sl)
|
2011-07-18 |
2018-09-28 |
Iba Gmbh |
Postopek za reverzibilno obarvanje tarčne celice
|
JP6322411B2
(ja)
|
2011-09-30 |
2018-05-09 |
中外製薬株式会社 |
複数の生理活性を有する抗原の消失を促進する抗原結合分子
|
TW201817744A
(zh)
|
2011-09-30 |
2018-05-16 |
日商中外製藥股份有限公司 |
具有促進抗原清除之FcRn結合域的治療性抗原結合分子
|
CA3233142A1
(en)
|
2011-11-30 |
2013-06-06 |
Chugai Seiyaku Kabushiki Kaisha |
Drug containing carrier into cell for forming immune complex
|
CN106940268B
(zh)
|
2012-02-23 |
2021-09-21 |
朱诺治疗有限公司 |
细胞和其它复杂生物材料的色谱分离
|
US9611306B2
(en)
|
2012-03-28 |
2017-04-04 |
The Board Of Regents Of The University Of Texas System |
TGFB type II-type III receptor fusions
|
CA2882272C
(en)
|
2012-08-24 |
2023-08-29 |
Chugai Seiyaku Kabushiki Kaisha |
Fc.gamma.riib-specific fc region variant
|
AU2014236208B2
(en)
|
2013-03-14 |
2018-07-19 |
Genvivo, Inc. |
Thymidine kinase diagnostic assay for gene therapy applications
|
EP2787006B1
(de)
|
2013-04-02 |
2018-02-28 |
Miltenyi Biotec GmbH |
Anti-CD8 Antikörper mit kalziumabhängiger Bindung
|
EP2982689B1
(de)
|
2013-04-02 |
2020-08-26 |
Chugai Seiyaku Kabushiki Kaisha |
Varianten der fc-region
|
JP6696969B2
(ja)
|
2014-04-16 |
2020-05-20 |
ユノ・セラピューティクス・ゲーエムベーハーJuno Therapeutics Gmbh |
細胞の集団を拡大する方法、キット、及び装置
|
AU2015254588B2
(en)
|
2014-04-30 |
2020-05-21 |
Iba Gmbh |
Method of isolating a target cell
|
CA2981509A1
(en)
|
2015-03-30 |
2016-10-06 |
The Board Of Regents Of The Nevada System Of Higher Educ. On Behalf Of The University Of Nevada, La |
Compositions comprising talens and methods of treating hiv
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
JP6924151B2
(ja)
|
2015-05-29 |
2021-08-25 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
免疫寛容及び非免疫寛容エラスチン様組換えペプチドならびに使用方法
|
NZ737423A
(en)
|
2015-06-01 |
2019-08-30 |
Medigene Immunotherapies Gmbh |
Method for generating antibodies against t cell receptor
|
EP3303591B1
(de)
|
2015-06-01 |
2019-04-03 |
Medigene Immunotherapies GmbH |
T-zell-rezeptor-bibliothek
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
WO2017068419A2
(en)
|
2015-10-22 |
2017-04-27 |
Juno Therapeutics Gmbh |
Methods, kits, agents and apparatuses for transduction
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
DK3394247T3
(da)
|
2015-12-23 |
2021-04-12 |
Medigene Immunotherapies Gmbh |
Ny generering af antigen-specifikke tcr'er
|
JP6758889B2
(ja)
|
2016-04-07 |
2020-09-23 |
シスメックス株式会社 |
標的タンパク質の精製方法
|
EP3443001A4
(de)
|
2016-04-11 |
2020-04-29 |
Obsidian Therapeutics, Inc. |
Regulierte bioschaltkreissysteme
|
CN109641941B
(zh)
|
2016-05-16 |
2023-06-16 |
哈佛大学校长及研究员协会 |
用于纯化和激活肉毒杆菌神经毒素的方法
|
CN109983133B
(zh)
|
2016-06-28 |
2023-09-08 |
慕尼黑工业大学 |
用于分析受体-配体Koff速率的可逆和不可逆细胞标记的组合
|
MA47325A
(fr)
|
2017-01-20 |
2019-11-27 |
Juno Therapeutics Gmbh |
Conjugués de surface cellulaire et compositions cellulaires et méthodes associées
|
WO2018148671A1
(en)
|
2017-02-12 |
2018-08-16 |
Neon Therapeutics, Inc. |
Hla-based methods and compositions and uses thereof
|
CN111032850A
(zh)
|
2017-04-27 |
2020-04-17 |
朱诺治疗学有限公司 |
寡聚粒子试剂及其使用方法
|
US11198722B2
(en)
|
2017-10-06 |
2021-12-14 |
University Of Utah Research Foundation |
Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use
|
KR102490850B1
(ko)
|
2018-02-26 |
2023-01-26 |
메디진 이뮤노테라피스 게엠바하 |
Nyeso t 세포 수용체
|
EP3806888B1
(de)
|
2018-06-12 |
2024-01-31 |
Obsidian Therapeutics, Inc. |
Von pde5 abgeleitete regulatorische konstrukte und verfahren zur verwendung in der immuntherapie
|
WO2020030631A1
(en)
|
2018-08-06 |
2020-02-13 |
Medigene Immunotherapies Gmbh |
Ha-1 specific t cell receptors and their use
|
WO2020048876A1
(en)
|
2018-09-03 |
2020-03-12 |
Technische Universitaet Muenchen |
A double peptide tag combining reversibility and flexible functionalization
|
WO2020086742A1
(en)
|
2018-10-24 |
2020-04-30 |
Obsidian Therapeutics, Inc. |
Er tunable protein regulation
|
US20220002669A1
(en)
|
2018-10-31 |
2022-01-06 |
Juno Therapeutics Gmbh |
Methods for selection and stimulation of cells and apparatus for same
|
EP3899954A4
(de)
|
2018-12-21 |
2022-09-14 |
BioNTech US Inc. |
Verfahren und systeme zur vorhersage von hla-klasse-ii-spezifischen epitopen und charakterisierung von cd4+-t-zellen
|
BR112021017744A2
(pt)
|
2019-03-08 |
2021-11-16 |
Obsidian Therapeutics Inc |
Composições e métodos de cd40l para regulação ajustável
|
EP3714941A1
(de)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4-tcrs
|
CN113840834A
(zh)
|
2019-04-04 |
2021-12-24 |
基因医疗免疫疗法有限责任公司 |
Magea1特异性t细胞受体及其用途
|
EP3983538A1
(de)
|
2019-06-12 |
2022-04-20 |
Obsidian Therapeutics, Inc. |
Ca2-zusammensetzungen und verfahren zur abstimmbaren regulierung
|
WO2020252404A1
(en)
|
2019-06-12 |
2020-12-17 |
Obsidian Therapeutics, Inc. |
Ca2 compositions and methods for tunable regulation
|
CA3146227A1
(en)
|
2019-07-09 |
2021-01-14 |
Medigene Immunotherapies Gmbh |
Magea10 specific t cell receptors and their use
|
WO2021046451A1
(en)
|
2019-09-06 |
2021-03-11 |
Obsidian Therapeutics, Inc. |
Compositions and methods for dhfr tunable protein regulation
|
JP2023500318A
(ja)
|
2019-10-30 |
2023-01-05 |
ジュノ セラピューティクス ゲーエムベーハー |
細胞選択および/または細胞刺激デバイスならびに使用方法
|
US11965882B2
(en)
|
2020-01-31 |
2024-04-23 |
Cell.Copedia GmbH |
Methods of isolating a biological entity
|
BR112023005296A2
(pt)
|
2020-09-24 |
2023-04-25 |
Medigene Immunotherapies Gmbh |
Receptores de células t específicos de mage-a3 e uso dos mesmos
|
WO2022235929A1
(en)
|
2021-05-05 |
2022-11-10 |
Radius Pharmaceuticals, Inc. |
Animal model having homologous recombination of mouse pth1 receptor
|
CN117916256A
(zh)
|
2021-05-06 |
2024-04-19 |
朱诺治疗学有限公司 |
用于刺激和转导t细胞的方法
|
KR20240005865A
(ko)
|
2021-05-07 |
2024-01-12 |
메디진 이뮤노테라피스 게엠바하 |
Prame 특이적 t 세포 수용체 및 키메라 공동 자극 수용체의 조합
|
GB202107222D0
(en)
|
2021-05-20 |
2021-07-07 |
Quell Therapeutics Ltd |
Method of treg isolation
|
WO2023017115A1
(en)
|
2021-08-11 |
2023-02-16 |
Iba Lifesciences Gmbh |
Fractionation of cells based on a marker protein
|
WO2023025779A1
(en)
|
2021-08-25 |
2023-03-02 |
Medigene Immunotherapies Gmbh |
Combination of antigen specific t cell receptors and chimeric co-stimulatory receptors
|
WO2023213969A1
(en)
|
2022-05-05 |
2023-11-09 |
Juno Therapeutics Gmbh |
Viral-binding protein and related reagents, articles, and methods of use
|
WO2024041761A1
(en)
|
2022-08-23 |
2024-02-29 |
Medigene Immunotherapies Gmbh |
Combination of ny-eso-1 specific t cell receptors and chimeric co-stimulatory receptors
|
WO2024100604A1
(en)
|
2022-11-09 |
2024-05-16 |
Juno Therapeutics Gmbh |
Methods for manufacturing engineered immune cells
|
GB202307533D0
(en)
|
2023-05-19 |
2023-07-05 |
Quell Therapeutics Ltd |
Method of treg isolation
|